References
[1] Guerrero-Pérez F, Marengo AP, Vilarrasa N, Vidal N, Ruiz-Roig N, Sánchez-Fernández JJ, Torres-Díaz A, Sanmillán JL, Pérez-Maraver M, Villabona C. Xanthogranuloma of the
sellar region : A systematic review. Hormones (Athens). 2023 Jun ;22(2) :199-210.
[2] Lozovanu V, Georgescu CE, Florescu LM, Georgiu C, Silaghi H, Fratea A, Silaghi CA. Xanthogranuloma of the Sellar Region: A Comprehensive Review of Neuroimaging in a Rare
Inflammatory Entity. J Pers Med. 2022 Jun 8;12(6):943.
[3] Alharbi A, Alkhaibary A, Alaglan A, Khairy S, Alkhunaizi Z, AlSufiani F, Alassiri AH, Alkhani A. Sellar xanthogranuloma: A diagnostic challenge. Surg Neurol Int. 2022 Mar 4; 13:76.
[4] Cheng D, Yang F, Li Z, Qv F, Liu W. Juvenile Xanthogranuloma of the Sellar Region with a 5-Year Medical History: Case Report and Literature Review. Pediatr Neurosurg.
2021;56(5):440-447.
[5] La Rocca G, Rigante M, Gessi M, D'Alessandris QG, Auricchio AM, Chiloiro S, De Marinis L, Lauretti L. Xanthogranuloma of the sellar region: A rare tumor. Case illustration and
literature review. J Clin Neurosci. 2019 Jan; 59:318-324.
[6] Rios IS, Silva DR, Goncalves PE, Souza Junior JF, Gurgel RQ, Oliveira AMP. Juvenile xanthogranuloma as a differential diagnosis for sellar and suprasellar lesions in child: Case
report and review of literature. Neurochirurgie. 2023 Sep;69(5):101472.
[7] Kobayashi M, Yagasaki H, Kobayashi K, Ogiwara M, Kinouchi H, Sugita K. Xanthogranuloma of the sellar region accompanied by growth hormone deficiency: case report and
literature review. J Pediatr Endocrinol Metab. 2018 Oct 25;31(10):1161-1164.
[8] Gurcay AG, Gurcan O, Kazanci A, Bozkurt I, Senturk S, Ferat M, Turkoglu OF, Beskonakli E, Orhun Yavuz HS. Xanthogranuloma of the sellar region. Neurol India. 2016 Sep-
Oct;64(5):1075-9.
[9] Shao X, Wang C, Min J. Xanthogranuloma of the sellar region: A case report. Medicine (Baltimore). 2020 Oct 2;99(40): e22619.
[10] Dai CX, Guo XS, Liu XH, Bao XJ, Feng M, Zhong DR, Ma WB, Wang RZ, Yao Y. Xanthogranuloma of the Sellar Region. Chin Med J (Engl). 2017 Jan 20;130(2):249-250.
Discussion
Xanthogranuloma of the sellar region is a rare entity that mostly presents in children, adolescents, and young adults [3]. Annual
incidence approximates 0.05 per million inhabitants. Tumors occur in the choroid plexus of the lateral ventricles, and rarely in
the sellar and parasellar region [4]. Xanthogranulomas were distinguished from craniopharyngiomas first in 1999 [5]. Sellar
Xanthogranulomas are characterized by the presence of cholesterol crystals, hemosiderin deposits, lymphocytic infiltrates,
macrophage accumulation, fibrous proliferation, and sparse clusters of epithelial cells [6]. However, they are still frequently
misdiagnosed as craniopharyngiomas due to their macroscopic intraoperative features and the occasional presence of epithelial
components. Clinical symptoms are of wide range and remain nonspecific. Xanthogranulomas may be responsible of several
neurological and endocrine disorders such as visual impairment due to optic chiasm compression, panhypopituitarism, diabetes
insipidus of central origin, and obstructive hydrocephalus [7]. Magnetic resonance imaging (MRI) is crucial step in the
management of this entity. However, features are rarely specific. Cholesterol crystals are observed hyperintense on T1 weighted
image and hypointense on T2. Hemosiderin cysts are iso or hyperintense on T1 sequence and hyperintense on T2. Fibrosis is
hypointense on T1 and T2 images. After gadolinium administration, enhancement is usually heterogeneous [8].
Surgical resection is necessary and reduce mass effect neurological consequences. The evolution of the hormonal deficiency is
variable. In our case, the patient’s hormonal deficits did not improve, and she resumed her endocrine replacement therapy. The
histopathological examination of the excised specimen confirms the Xanthogranuloma diagnosis in most of the cases.